REGULATION OF TGF-beta ACTIVITY FOR ATTENUATION OF GLOMERULAR LESIONS
调节 TGF-β 活性以减轻肾小球病变
基本信息
- 批准号:08671289
- 负责人:
- 金额:$ 1.34万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1996
- 资助国家:日本
- 起止时间:1996 至 1997
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
1.The latency of TGF-beta and chronicity of renal diseasesOur previous studies demonstrated that in a chronic renal disease model, most of TGF-beta is not activated and exsits as a latent form in tissue. The tissue storage of latent TGF-beta may be important for chronicity of histological changes. Tissue localization of latent TGF-beta was examined in vitro and in vivo. The matrices from mesangial cell cultures were shown to contain a large amount of latent TGF-beta. In an experimental FGS model, latent TGF-beta accumulates in the sclerosing glomeruli and the fibrous interstitium extensively and coexists with the other matrix proteins. The matrix-associated latent TGF-beta may serve as a chronic stimulus driving new ECM synthesis, which is important for both keeping and developing sclerosis or fibrotic tissues.2.The effect of TGF-beta soluble receptor on renal fibrosisThe TGF-beta soluble receptor, which is extracellular domain of TGF-beta type 2 receptor has been expected to inhibit TGF-beta action in renal diseases. The gene of the soluble receptor was transfectd to muscle in rats with unilateral ureter obstruction, using adenovirus vectors. The interstitial fibrosis was attenuated in association with the increased serum levels of the soluble receptor. TGF-beta soluble receptor is a potent inhibitor of TGF-beta to modulate renal histological lesions.
1. TGF-beta的潜伏期和肾脏疾病的慢性性先前的研究表明,在慢性肾脏疾病模型中,大多数TGF-β没有被激活,并且在组织中作为潜在形式。潜在TGF-β的组织存储对于组织学变化的慢性性可能很重要。在体外和体内检查了潜在TGF-β的组织定位。显示出来自肾小球细胞培养物的矩阵包含大量潜在的TGF-β。在实验性FGS模型中,潜在的TGF-β积累在硬化肾小球和纤维间质中,并与其他基质蛋白共存。 The matrix-associated latent TGF-beta may serve as a chronic stimulus driving new ECM synthesis, which is important for both keeping and developing sclerosis or fibrotic tissues.2.The effect of TGF-beta soluble receptor on renal fibrosisThe TGF-beta soluble receptor, which is extracellular domain of TGF-beta type 2 receptor has been expected to inhibit TGF-beta action在肾脏疾病中。使用腺病毒载体,可溶性受体的基因转染为具有单侧输尿管阻塞的大鼠的肌肉。与可溶性受体的血清水平升高相关的间质纤维化。 TGF-β溶解受体是TGF-β的有效抑制剂,可调节肾脏组织学病变。
项目成果
期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kubo M,Hirakata H,Okuda S et al: "Angiotensin I converting enzume inhibitor and worsening of anemia in hemodialysis patients : Prevention with rHuEPO." J Jpn Dial Ther. 30. 315-320 (1997)
Kubo M、Hirakata H、Okuda S 等人:“血管紧张素 I 转换酶抑制剂和血液透析患者贫血恶化:用 rHuEPO 预防。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Okuda S: "Role of endothelin as a mitogen in experimental glomerulonephritis in rats." Kidney Int. 49. 1320-1329 (1996)
Okuda S:“内皮素作为有丝分裂原在大鼠实验性肾小球肾炎中的作用。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Fukuda K: "Role of endothelin as a mitogen in experimental glomerulonephritis in rats." Kidney International. 49. 1320-1329 (1996)
Fukuda K:“内皮素作为有丝分裂原在大鼠实验性肾小球肾炎中的作用。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Nakayama M: "Short-or long term effects of a low-protein diet on fibronectin and transforming growth factor-β synthesis in adriamycin-induced nephropathy." Journal of Labratory of Clinical Medicine. 127. 29-39 (1996)
Nakayama M:“低蛋白饮食对阿霉素诱发肾病中纤连蛋白和转化生长因子-β 合成的短期或长期影响。临床医学实验室杂志 127. 29-39 (1996)”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Okuda S: "Short-or long term effects of a low-protein diet on fibronectin and ransforming growth factor-b synthesis in adriamycin-induced nephropathy." J Lab Clin Med. 127. 29-39 (1996)
Okuda S:“低蛋白饮食对阿霉素诱发肾病中纤连蛋白和转化生长因子 B 合成的短期或长期影响。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
OKUDA Seiya其他文献
OKUDA Seiya的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('OKUDA Seiya', 18)}}的其他基金
Missing link between metabolic syndrome and chronic kidney disease.?Role of asymmetric dimethylarginine-
代谢综合征和慢性肾脏病之间缺失联系。?不对称二甲基精氨酸的作用-
- 批准号:
22590903 - 财政年份:2010
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
ADMA metabolism and microvascular damage in chronic renal diseases
慢性肾脏病中ADMA代谢与微血管损伤
- 批准号:
19590971 - 财政年份:2007
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
ROLE OF AND REGULATION OF GROWTH FACTOR TGF-β IN GLOMERULAR LESIONS
生长因子TGF-β在肾小球病变中的作用和调节
- 批准号:
15590869 - 财政年份:2003
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
REGULATION OF TGF_ACTIVITY FOR ATTENUATION OF GLOMERULAR LESIONS
调节 TGF_活性以减弱肾小球病变
- 批准号:
13671133 - 财政年份:2001
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
REGULATION OF TGF-β ACTIVITY FOR ATTENUATION OF GLOMERULAR LESIONS
调节 TGF-β 活性以减轻肾小球病变
- 批准号:
10470219 - 财政年份:1998
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
THE PERSISTENT ACTIVATION MECHANISM OF TGF-b IN PROGRESSIVE GLOMERULAR DISEASES
进展性肾小球疾病中TGF-b的持续激活机制
- 批准号:
06671143 - 财政年份:1994
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似国自然基金
TGF-beta通路通过降低自噬-基因组稳定性介导胶质母细胞瘤间质亚型替莫唑胺耐药的机制研究
- 批准号:82303919
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
转录因子FOXA1对TGF-beta介导的肺癌细胞上皮-间充质转化调控作用的研究
- 批准号:32200434
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
癌基因FBN2通过TGF-beta通路促进胃癌肝转移的分子机制研究
- 批准号:82273445
- 批准年份:2022
- 资助金额:52.00 万元
- 项目类别:面上项目
癌基因FBN2通过TGF-beta通路促进胃癌肝转移的分子机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
转录因子FOXA1对TGF-beta介导的肺癌细胞上皮-间充质转化调控作用的研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
ROLE OF NOVEL SOLUBLE TGF-BETA RECEPTOR IN THE KIDNEY
新型可溶性 TGF-β 受体在肾脏中的作用
- 批准号:
6517739 - 财政年份:2000
- 资助金额:
$ 1.34万 - 项目类别:
ROLE OF NOVEL SOLUBLE TGF-BETA RECEPTOR IN THE KIDNEY
新型可溶性 TGF-β 受体在肾脏中的作用
- 批准号:
6087959 - 财政年份:2000
- 资助金额:
$ 1.34万 - 项目类别:
ROLE OF NOVEL SOLUBLE TGF-BETA RECEPTOR IN THE KIDNEY
新型可溶性 TGF-β 受体在肾脏中的作用
- 批准号:
6348753 - 财政年份:2000
- 资助金额:
$ 1.34万 - 项目类别:
ROLE OF NOVEL SOLUBLE TGF-BETA RECEPTOR IN THE KIDNEY
新型可溶性 TGF-β 受体在肾脏中的作用
- 批准号:
6381798 - 财政年份:2000
- 资助金额:
$ 1.34万 - 项目类别:
ROLE OF NOVEL SOLUBLE TGF-BETA RECEPTOR IN THE KIDNEY
新型可溶性 TGF-β 受体在肾脏中的作用
- 批准号:
6635250 - 财政年份:2000
- 资助金额:
$ 1.34万 - 项目类别: